麻豆果冻传媒影音

People with advanced lung cancer represent a distinct group whose needs remain understudied, especially compared with people diagnosed with limited-stage disease. Fortunately, novel treatments such as tyrosine kinase inhibitors and immune checkpoint inhibitors are leading to significant advances in prognosis and survival, even among those with advanced disease at the time of diagnosis.

However, there are known gaps in symptom management, psychosocial and nutritional support, complex care coordination, health behavior coaching, and healthcare delivery efforts among patients living with advanced lung cancer.

Many of these patients would benefit from survivorship and palliative care approaches. In particular, survivorship care may include healthcare maintenance, treatment of immune-related adverse events and late- or long-term effects, frailty assessment and rehabilitation, and care coordination.

Palliative care may be best suited to discuss ongoing symptom management, advanced care planning, and end-of-life considerations, as well as psychosocial well-being.

To this end, we share a review of the current status of the palliative and survivorship care infrastructure for patients with advanced lung cancer and provide suggestions across the care continuum for this diverse group of patients and families.

Read a Q&A related to the review here and expert commentary about it here.